Sorrento Therapeutics, Inc. announced the unexpected passing of Mr. Najjam Asghar, Senior Vice President. Mr. Asghar died of apparent natural causes on January 6, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0071 USD | -29.00% |
|
-25.26% | -94.25% |
Apr. 10 | Sorrento Therapeutics, Inc. Emerged from Bankruptcy | CI |
Mar. 15 | Scilex Settles Claims in Case Against Virpax for $6 Million, 6% Royalties From Three Drugs | MT |
1st Jan change | Capi. | |
---|---|---|
-94.25% | 3.86M | |
+15.58% | 121B | |
+16.60% | 110B | |
+18.20% | 25.98B | |
-24.33% | 19.27B | |
-18.40% | 15.99B | |
-17.95% | 15.66B | |
-48.32% | 14.5B | |
+58.78% | 14.47B | |
+4.91% | 13.91B |
- Stock Market
- Equities
- SRNE Stock
- News Sorrento Therapeutics, Inc.
- Sorrento Therapeutics, Inc. Announces Demise of Najjam Asghar, Senior Vice President